{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:17:14Z","timestamp":1791825434351,"version":"4.3.4"},"reference-count":48,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec sec-type=\"background\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Published evidence on patient experiences, perceptions, and challenges related to early breast cancer (eBC) in Italy is limited. Understanding these aspects is critical for improving diagnosis, treatment outcomes, and quality of life (QoL).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"objective\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study used social media listening (SML) to explore the patient journey, treatment perceptions, QoL, and unmet needs of patients with eBC, caregivers, and health care professionals (HCPs) in Italy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"methods\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective noninterventional SML study analyzed publicly available posts from December 2021 to November 2023 using breast cancer\u2013related keywords in English and Italian through Sprinklr, a web-based aggregator tool. Posts sourced from social media platforms, such as X (formerly known as Twitter), blogs, forums, Facebook, Instagram, and YouTube, were filtered by geographic location to include only users in Italy. Posts were filtered using natural language processing (NLP) for relevance and duplicates, followed by manual review and stakeholder identification (patients, caregivers, and HCPs). Key themes of discussion were identified through thematic analysis of posts across the stages of the patient journey (symptoms, diagnosis, treatment, etc). Ethical guidelines were followed by using anonymized, publicly available data. Descriptive statistics were used to analyze the data, and posts with missing data were excluded. Consequently, denominators varied across analyses and were adjusted based on data availability for specific variables.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"results\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 20,008 posts initially extracted, 1580 posts were retained following NLP filtering, and 530 posts were included after manual screening. The majority (493\/518, 95%) of the posts were sharing information about diagnosis and treatment journeys, emotional challenges, QoL concerns, and symptoms (eg, lumps, breast pain), while 27% (141\/518) of the posts sought information on diagnostic dilemmas, treatment options, and second opinions. Patients contributed 60% (318\/530) of the posts, and caregivers contributed 21% (111\/530) of the posts, with over half (57\/107, 53%) discussing their mothers\u2019 diagnosis and treatment struggles. HCPs contributed 16% (85\/530) of the posts, primarily sharing clinical trial updates, drug approvals, and disease awareness efforts. A total of 88 posts included discussions on QoL, and eBC significantly impacted patients\u2019 emotional, physical, functional, and social well-being. Discussions revealed key unmet needs, including limited awareness of adjuvant therapy options, lack of peer support groups, suboptimal patient-HCP communication, and insufficient access to specialty care facilities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"conclusions\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study highlights gaps in eBC management related to patient education, HCP communication, and access to specialty care and describes an associated worsening of QoL for patients as reflected in social media posts. Within the limitations of an observational SML design, increasing patient and caregiver awareness of available adjuvant therapies to improve adherence and reduce recurrence risk, alongside expanding access to regional breast cancer centers, may help optimize patient experiences and outcomes. Further research using complementary data sources is needed to confirm and extend these findings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2196\/73371","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T18:11:36Z","timestamp":1774375896000},"page":"e73371-e73371","source":"Crossref","is-referenced-by-count":1,"title":["Exploring the Experiences and Perspectives of Patients With Early Breast Cancer, Caregivers, and Health Care Professionals: Italian Social Media Listening Study"],"prefix":"10.2196","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9139-7538","authenticated-orcid":false,"given":"Matteo Basilio","family":"Suter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7013-6612","authenticated-orcid":false,"given":"Rosanna","family":"D'Antona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3095-0448","authenticated-orcid":false,"given":"Manuelita","family":"Mazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1011-399X","authenticated-orcid":false,"given":"Enrica","family":"Francavilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1608-3119","authenticated-orcid":false,"given":"Alice","family":"Messi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9470-1472","authenticated-orcid":false,"given":"Abhinav","family":"Maurya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3784-9426","authenticated-orcid":false,"given":"Shiva","family":"Padhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3268-0876","authenticated-orcid":false,"given":"Diletta","family":"Valsecchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2026,3,24]]},"reference":[{"issue":"3","key":"R1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","journal-title":"CA Cancer J Clin"},{"key":"R2","unstructured":"I numeri del cancro in Italia 2023 [Report in Italian]. Associazione Italiana di Oncologia Medica (AIOM); 2023. URL: https:\/\/www.aiom.it\/wp-content\/uploads\/2023\/12\/2023_AIOM_NDC-web.pdf [Accessed 24-02-2026]"},{"issue":"1","key":"R3","doi-asserted-by":"publisher","first-page":"10","DOI":"10.33393\/ao.2024.2634","article-title":"Follow-up of breast cancer: why is it necessary to start a Consensus in 2024?","volume":"11","author":"Gori","journal-title":"AboutOpen"},{"key":"R4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2019.05.004","article-title":"Adjuvant zoledronic acid and letrozole plus ovarian function suppression in premenopausal breast cancer: HOBOE phase 3 randomised trial","volume":"118","author":"Perrone","journal-title":"Eur J Cancer"},{"key":"R5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2018.06.006","article-title":"Patient-reported symptoms after breast cancer diagnosis and treatment: a retrospective cohort study","volume":"101","author":"Davis","journal-title":"Eur J Cancer"},{"issue":"3","key":"R6","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-021-01049-3","article-title":"Psychological aspects to consider in breast cancer diagnosis and treatment","volume":"23","author":"Dinapoli","journal-title":"Curr Oncol Rep"},{"issue":"1","key":"R7","doi-asserted-by":"publisher","DOI":"10.1186\/s41687-022-00422-5","article-title":"Cancer treatment regimens and their impact on the patient-reported outcome measures health-related quality of life and perceived cognitive function","volume":"6","author":"Grusdat","journal-title":"J Patient Rep Outcomes"},{"issue":"1","key":"R8","first-page":"23","volume":"9","author":"Blumen","journal-title":"Am Health Drug Benefits"},{"issue":"1","key":"R9","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/MLR.0b013e3181f81c32","article-title":"Cost of breast cancer treatment in Medicaid: implications for state programs providing coverage for low-income women","volume":"49","author":"Subramanian","journal-title":"Med Care"},{"issue":"6","key":"R10","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare11060797","article-title":"Measuring patient experience and patient satisfaction\u2014how are we doing it and why does it matter? A comparison of European and US American approaches","volume":"11","author":"Friedel","journal-title":"Healthcare (Basel)"},{"issue":"1","key":"R11","first-page":"28","volume":"1","author":"Lavela","journal-title":"Patient Exp J"},{"issue":"1","key":"R12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1080\/13814788.2017.1375091","article-title":"Series: practical guidance to qualitative research. Part 3: sampling, data collection and analysis","volume":"24","author":"Moser","journal-title":"Eur J Gen Pract"},{"key":"R13","doi-asserted-by":"publisher","DOI":"10.1177\/20552076241257146","article-title":"The advantages, disadvantages, threats, and opportunities of electronic patient-reported outcome systems in cancer: a systematic review","volume":"10","author":"Salmani","journal-title":"Digit Health"},{"issue":"1","key":"R14","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-56679-x","article-title":"Characterizing user demographics in posts related to breast, lung and colon cancer on Japanese Twitter (X)","volume":"14","author":"Kusudo","journal-title":"Sci Rep"},{"key":"R15","doi-asserted-by":"publisher","DOI":"10.1200\/CCI.24.00038","article-title":"Insights into the patient experience of hormone therapy for early breast cancer treatment using patient forum discussions and natural language processing","volume":"8","author":"Sreenivasan","journal-title":"JCO Clin Cancer Inform"},{"issue":"5","key":"R16","doi-asserted-by":"publisher","DOI":"10.2196\/16902","article-title":"Exploring strategies for using social media to self-manage health care when living with and beyond breast cancer: in-depth qualitative study","volume":"22","author":"Ure","journal-title":"J Med Internet Res"},{"key":"R17","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1274688","article-title":"Patient listening on social media for patient-focused drug development: a synthesis of considerations from patients, industry and regulators","volume":"11","author":"Cimiano","journal-title":"Front Med (Lausanne)"},{"key":"R18","unstructured":"For industry: using social media. US Food and Drug Administration (FDA). 2024. URL: https:\/\/www.fda.gov\/about-fda\/center-drug-evaluation-and-research-cder\/industry-using-social-media [Accessed 21-08-2024]"},{"key":"R19","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.863641","article-title":"Social media listening to understand the lived experience of individuals in Europe with metastatic breast cancer: a systematic search and content analysis study","volume":"12","author":"Mazza","journal-title":"Front Oncol"},{"issue":"5","key":"R20","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2024.103007","article-title":"Perception of cure in prostate cancer: human-led and artificial intelligence-assisted landscape review and linguistic analysis of literature, social media and policy documents","volume":"9","author":"Efstathiou","journal-title":"ESMO Open"},{"key":"R21","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2023.09.2807","article-title":"1858P Discrepancies between psychological stress and emotional care in cancer patients revealed in a social listening analysis","volume":"34","author":"Kim","journal-title":"Ann Oncol"},{"issue":"10","key":"R22","doi-asserted-by":"publisher","DOI":"10.2196\/11515","article-title":"Nature and diffusion of gynecologic cancer\u2013related misinformation on social media: analysis of tweets","volume":"20","author":"Chen","journal-title":"J Med Internet Res"},{"issue":"12","key":"R23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2023.09.2463","article-title":"PCR24 Patient and caregiver perceptions of systemic anticancer treatments in advanced bladder cancer (aBC): results of a social media listening (SML) study conducted in 5 European countries (Eu5)","volume":"26","author":"Sch\u00fcck","journal-title":"Value Health"},{"key":"R24","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-1683(23)01564-1","article-title":"Awareness about genitourinary cancer in North Africa\u2014social listening analytics","volume":"57","author":"Yekrou","journal-title":"Eur Urol Open Sci"},{"key":"R25","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2021.08.1944","article-title":"1343P Understanding patient and caregiver perceptions of quality of life (QoL) impacts in lung cancer through social listening","volume":"32","author":"Montrone","journal-title":"Ann Oncol"},{"issue":"9","key":"R26","doi-asserted-by":"publisher","DOI":"10.2196\/18306","article-title":"Social media listening to understand the lived experience of presbyopia: systematic search and content analysis study","volume":"22","author":"Wolffsohn","journal-title":"J Med Internet Res"},{"issue":"11","key":"R27","doi-asserted-by":"publisher","DOI":"10.2196\/26272","article-title":"A neural network approach for understanding patient experiences of chronic obstructive pulmonary disease (COPD): retrospective, cross-sectional study of social media content","volume":"9","author":"Freeman","journal-title":"JMIR Med Inform"},{"issue":"1","key":"R28","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-09505-4","article-title":"Understanding the lived experience of lung cancer: a European social media listening study","volume":"22","author":"Rodrigues","journal-title":"BMC Cancer"},{"key":"R29","unstructured":"Sprinklr. URL: https:\/\/www.sprinklr.com\/products\/consumer-intelligence\/social-listening [Accessed 01-12-2023]"},{"issue":"1","key":"R30","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-016-1691-0","article-title":"Social media use in healthcare: a systematic review of effects on patients and on their relationship with healthcare professionals","volume":"16","author":"Smailhodzic","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"R31","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s10549-024-07406-7","article-title":"Patient-reported observations on medical procedure timeliness (PROMPT) in breast cancer: a qualitative study","volume":"208","author":"Fefferman","journal-title":"Breast Cancer Res Treat"},{"issue":"Suppl 10","key":"R32","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1002\/cncr.32887","article-title":"Breast cancer early detection: a phased approach to implementation","volume":"126","author":"Ginsburg","journal-title":"Cancer"},{"issue":"4","key":"R33","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1111\/j.1349-7006.1992.tb00113.x","article-title":"The effect of breast self-examination on early detection and survival","volume":"83","author":"Kuroishi","journal-title":"Jpn J Cancer Res"},{"issue":"33","key":"R34","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000021695","article-title":"Relationship between chemotherapy-induced adverse reactions and health-related quality of life in patients with breast cancer","volume":"99","author":"Prieto-Callejero","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"R35","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.6937","article-title":"Identifying determinants of adherence to adjuvant endocrine therapy following breast cancer: a systematic review of reviews","volume":"13","author":"Todd","journal-title":"Cancer Med"},{"issue":"11","key":"R36","doi-asserted-by":"publisher","first-page":"5075","DOI":"10.1007\/s00520-020-05585-9","article-title":"Adherence to adjuvant endocrine therapy among breast cancer survivors: a systematic review and meta-synthesis of the qualitative literature using grounded theory","volume":"28","author":"AlOmeir","journal-title":"Support Care Cancer"},{"issue":"7","key":"R37","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1038\/bjc.2013.116","article-title":"Cohort study of adherence to adjuvant endocrine therapy, breast cancer recurrence and mortality","volume":"108","author":"Makubate","journal-title":"Br J Cancer"},{"issue":"7","key":"R38","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/j.clinthera.2021.04.020","article-title":"Health-related quality of life among patients with HR+\/HER2\u2013early breast cancer","volume":"43","author":"Criscitiello","journal-title":"Clin Ther"},{"key":"R39","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2024.103331","article-title":"273P Experiences and preferences about information on treatment (tx)-related side effects (SE) among patients (pts) with early breast cancer (EBC)","volume":"9","author":"Di Meglio","journal-title":"ESMO Open"},{"key":"R40","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2024.08.1759","article-title":"1675P Impact of adjuvant hormonal therapy on sexual and global quality of life in young Egyptian women with breast cancer","volume":"35","author":"Korani","journal-title":"Ann Oncol"},{"issue":"1","key":"R41","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1007\/s12282-023-01520-y","article-title":"Fatigue and quality of life during neoadjuvant chemotherapy of early breast cancer: a prospective multicenter cohort study","volume":"31","author":"Pelzer","journal-title":"Breast Cancer (Auckl)"},{"key":"R42","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2024.113668","article-title":"Understanding patient experiences of early breast cancer treatment: informing future studies to reduce treatment burden","volume":"200","author":"Potter","journal-title":"Eur J Cancer"},{"issue":"1","key":"R43","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.pec.2020.06.030","article-title":"How to know what to know: information challenges for women in the diagnostic phase of breast cancer","volume":"104","author":"Ormel","journal-title":"Patient Educ Couns"},{"issue":"9","key":"R44","doi-asserted-by":"publisher","first-page":"3826","DOI":"10.1111\/jocn.17598","article-title":"Information needs among Thai women breast cancer patients during the initial treatment phase: a cross-sectional study","volume":"34","author":"Rattanakanlaya","journal-title":"J Clin Nurs"},{"issue":"7","key":"R45","doi-asserted-by":"publisher","DOI":"10.2196\/17907","article-title":"Information needs of breast cancer patients: theory-generating meta-synthesis","volume":"22","author":"Lu","journal-title":"J Med Internet Res"},{"key":"R46","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.32852","article-title":"Breast cancer patient advocacy: a qualitative study of the challenges and opportunities for civil society organizations in low-income and middle-income countries","volume":"126","author":"Dvaladze","journal-title":"Cancer"},{"issue":"11","key":"R47","doi-asserted-by":"publisher","DOI":"10.2196\/12035","article-title":"Health care professionals' social media behavior and the underlying factors of social media adoption and use: quantitative study","volume":"20","author":"Hazzam","journal-title":"J Med Internet Res"},{"issue":"7","key":"R48","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.16350","article-title":"A study to see the effect of social media usage among healthcare providers","volume":"13","author":"Khan","journal-title":"Cureus"}],"container-title":["JMIR Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/cancer.jmir.org\/2026\/1\/e73371","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T18:03:57Z","timestamp":1782842637000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancer.jmir.org\/2026\/1\/e73371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,24]]},"references-count":48,"URL":"https:\/\/doi.org\/10.2196\/73371","relation":{},"ISSN":["2369-1999"],"issn-type":[{"value":"2369-1999","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,24]]},"article-number":"v12i3e73371"}}